30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

TOMSICEK MICHAEL JOHN

Insider profile

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
TOMSICEK MICHAEL JOHN's trades of Milestone Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-10-21 2022-10-19 B Purchase
63,789 -15.5%
293.63
US$4,342,090
63,789 -15.5% 293.63 US$4,342,090
2020-09-03 2020-09-01 PlS Planned sale
64,477 -1.6%
80.57
US$2,028,466
64,477 -1.6% 80.57 US$2,028,466
2020-09-03 2020-09-01 PlS Planned sale
50,999 +34.4%
159.71
US$3,469,457
50,999 +34.4% 159.71 US$3,469,457
2020-09-03 2020-09-01 PlS Planned sale
2,800 -22.6%
91.39
US$255,892
2,800 -22.6% 91.39 US$255,892
2020-08-05 2020-08-03 PlS Planned sale
5,448 -93.0%
87.33
US$475,790
5,448 -93.0% 87.33 US$475,790
2020-08-05 2020-08-03 PlS Planned sale
6,552 -52.8%
86.25
US$565,128
6,552 -52.8% 86.25 US$565,128